Quest Diagnostics Inc logo

DGX - Quest Diagnostics Inc News Story

$121.24 -4.0  -3.2%

Last Trade - 10/08/20

Sector
Healthcare
Size
Large Cap
Market Cap £12.46bn
Enterprise Value £15.30bn
Revenue £5.76bn
Position in Universe 537th / 6400

BRIEF-FDA Authorizes Quest Diagnostics Covid-19 Nasal Specimen Self-Collection Kit For Emergency Use

Thu 28th May, 2020 6:09pm
May 28 (Reuters) - Quest Diagnostics Inc  DGX.N :
    * FDA AUTHORIZES QUEST DIAGNOSTICS COVID-19 NASAL SPECIMEN
SELF-COLLECTION KIT FOR EMERGENCY USE
    * QUEST DIAGNOSTICS INC - PLANS TO MAKE SELF-COLLECTION KITS
AVAILABLE THROUGH SEVERAL CHANNELS
    * QUEST DIAGNOSTICS INC - EXPECTS TO HAVE MORE THAN A
HALF-MILLION
KITS AVAILABLE BY END OF JUNE

Source text for Eikon:  ID:nPn4Z2WJga 
Further company coverage:  DGX.N 

 ((Reuters.briefs@thomsonreuters.com;))
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.